Marine functional #connectivity matters—from genes to energy flows. This synthesis clarifies concepts, unifies fragmented approaches, and proposes a global framework to better link science, #SpatialPlanning, and #policy in a changing ocean. doi.org/10.1002/brv....
#MarineEcology 🌐🌍🧪🌊
Posts by David Despain (he/him/el)
🥀 🧪 Jane Goodall 1934-2025
Fig. 2: New hominin dentition from the LGRP.
Hominin fossils from the Ledi-Geraru Research Project area, Ethiopia, suggest that early Homo and Australopithecus species co-existed in the region more than 2.5 million years ago, according to a paper published in Nature. go.nature.com/45Np847🏺 🧪
I really enjoyed this article on the brain's glymphatic system, from the discovery of how brains "wash" themselves" to new frontiers including "glymphograms" to measure brain clearance efficiency. I'm looking forward to seeing where this research leads in the years ahead. Now, time for bed.
The Need for Speed: Improving Muscle Power for Longevity - Mayo Clinic Proceedings www.mayoclinicproceedings.org/article/S002...
adding SARS-CoV-2 Mpro (in red, purple, blue, gray, little green) to a test tube with pink plasma, causes activation of VII and XII (red circles) to make a blood clot (RBCs with yellow platelets and yellow fibrin)
🩸A new study shows that adding SARS-CoV-2’s main protease (Mpro) enzyme to plasma from healthy donors can trigger blood clots by activating coagulation factors VII and XII. buff.ly/hWZB7aS
🩸This may help explain why COVID increases blood clot risk.
#medsky #hemesky #IDsky 🛟😷🧪
The Science I Would Be Doing if I Weren’t in ICE Detention
By Kseniia Petrova
"Ms. Petrova is a Russian scientist who works in a lab at Harvard Medical School. She told her story through a Times Opinion editor, Alex Ellerbeck, over multiple calls from an ICE detention center."
The National Weather Service costs the average American $4 and prevents billions of dollars of damage PER YEAR. One in three local offices are now "critically understaffed" while summer's weather threats loom. 🧪 www.scientificamerican.com/article/how-...
Lilly's oral GLP-1 drug completes phase 3 trial, up for FDA approval for weight loss this year, T2D in 2026
Interesting. Overall from the study, looks like a 11-14% reduction in risk of all-cause dementia, and 12-19% reduction in risk of AD in APOE4 non-carriers (depending on score) -- that is meaningful -- but no effect on APOE4 carriers.